TATVA CHINTAN PHARMA CHEM LTD.
Quaterly Results
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Audited / UnAudited | UnAudited | UnAudited | UnAudited | UnAudited |
Net Sales | 842.06 | 966.69 | 1143.64 | 1245.11 |
Total Expenditure | 732.12 | 764.21 | 930.21 | 1082.37 |
PBIDT (Excl OI) | 109.94 | 202.48 | 213.43 | 162.74 |
Other Income | 12.1 | 7.56 | 10.15 | 8.45 |
Operating Profit | 122.04 | 210.04 | 223.58 | 171.19 |
Interest | 3.77 | 30.14 | 29.26 | 31.99 |
Exceptional Items | NA | NA | NA | -35.87 |
PBDT | 118.27 | 179.9 | 194.32 | 103.33 |
Depreciation | 65.83 | 67.77 | 60.12 | 25.31 |
Profit Before Tax | 52.44 | 112.13 | 134.2 | 78.02 |
Tax | 17.89 | 34.32 | 39.16 | -91.52 |
Provisions and contingencies | NA | NA | NA | NA |
Profit After Tax | 34.55 | 77.81 | 95.03 | 169.54 |
Extraordinary Items | NA | NA | NA | NA |
Prior Period Expenses | NA | NA | NA | NA |
Other Adjustments | NA | NA | NA | NA |
Net Profit | 34.55 | 77.81 | 95.03 | 169.54 |
Minority Interest | NA | NA | NA | NA |
Shares of Associates | ||||
Other related items | ||||
Misc. Expenses Written off | NA | NA | NA | NA |
Consolidated Net Profit | 34.55 | 77.81 | 95.04 | 169.54 |
Equity Capital | 233.92 | 233.92 | 221.65 | 221.65 |
Face Value (IN RS) | 10 | 10 | 10 | 10 |
Reserves | NA | NA | NA | NA |
Calculated EPS | 1.47 | 3.32 | 4.28 | 7.64 |
Calculated EPS (Annualised) | 5.90 | 13.30 | 17.15 | 30.59 |
No of Public Share Holdings | 6545097 | 6545097 | 4616804 | 4616804 |
% of Public Share Holdings | 27.98 | 27.98 | 20.83 | 20.83 |
| NA | NA | NA | NA |
PBIDTM% (Excl OI) | 13.05 | 20.94 | 18.66 | 13.07 |
PBIDTM% | 14.49 | 21.72 | 19.54 | 13.74 |
PBDTM% | 14.04 | 18.60 | 16.99 | 8.29 |
PBTM% | 6.22 | 11.59 | 11.73 | 6.26 |
PATM% | 4.10 | 8.04 | 8.31 | 13.61 |
"; | Notes | Notes | Notes | Notes |